SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as a market stabilizer following a blowout earnings report where accelerating Azure growth and clear AI monetization effectively countered recent investor skepticism regarding capital expenditure. The community is actively celebrating the stock's strong performance, with many bulls highlighting it as a critical pillar for the broader market while short sellers face significant pressure from the unexpected surge.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is experiencing extreme volatility and intense short-squeeze speculation as investors debate whether recent steep losses represent a buying opportunity in the AI infrastructure sector. The community is sharply divided between bulls citing massive hyperscaler capex and long-term AI demand, and skeptics emphasizing concerns over debt, margin call-driven liquidations, and broader market uncertainty.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing significant community debate following a series of robust operational updates, including record-breaking ABS issuances and positive shifts in analyst credit outlooks. While retail investors are actively discussing the stock's potential for a valuation re-rating compared to fintech peers, sentiment remains divided between those betting on long-term fundamental execution and others frustrated by persistent price volatility and broader macro headwinds.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is trending following a record-breaking earnings beat and raised full-year guidance that solidified its role in powering AI data centers. Investors are actively debating the stock's future, weighing institutional conviction and strong operational momentum against broader market volatility.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's approval of Anktiva for both BCG-unresponsive bladder cancer and metastatic non-small cell lung cancer, marking a significant expansion of its global footprint. While community sentiment remains polarized between optimistic bulls focusing on this regulatory momentum and bearish traders highlighting the stock's recent volatility and ongoing short interest, investors are now shifting their attention to the upcoming quarterly earnings for confirmation of commercial sales growth.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing massive volatility as traders react to a broader memory and semiconductor sector reversal, fueled by positive earnings read-throughs from Microsoft and hopes that the recent SK Hynix-led washout is finally behind the market. Community discussion remains polarized, with many retail traders hunting for a bottom while others warn that the stock remains extended and prone to further pressure.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is experiencing significant volatility as investors weigh a strong earnings beat and a massive contracted backlog against broader macro headwinds and sector-wide selling pressure. While the community is actively debating whether the current price action represents an orchestrated shakeout or a fundamental repricing of the data center infrastructure trade, sentiment remains polarized between those viewing the decline as a major buying opportunity and those concerned about the impact of high-beta market conditions.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending due to the release of its latest earnings report, which triggered sharp volatility as investors weighed a record-breaking quarter against full-year guidance that failed to meet lofty market expectations. The community remains deeply polarized, with active debates pitting bulls who point to sustained growth and operational execution against bears who continue to allege accounting irregularities and express skepticism regarding the company's subprime lending model.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to heightened community discussion surrounding an upcoming maintenance dosing data readout and anticipation for its Q2 earnings call. Investors are focused on the company's clinical pipeline progress, with many debating the implications of a recent board appointment and ongoing volatility driven by speculation regarding potential M&A activity.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is rebounding alongside the broader semiconductor sector as robust earnings from Samsung and positive capex signals from tech giants reinforce the long-term AI memory supercycle. While many in the community are actively debating whether this is a sustainable bottom or a relief rally before further volatility, there is strong focus on the impact of margin calls and KOSPI-linked algorithmic trading driving recent price swings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sanofi Q2 Net Profit Plunges, Business Profit Climbs On Strong Sales; Lifts FY26 Outlook

(RTTNews) - French drug major Sanofi SA (SNY, SNYNF, SAN.PA) reported Thursday sharply lower net profit in its second quarter, while business earnings climbed from last year with strong sales growth. Further, the firm upgraded its fiscal 2026 outlook...

Will REGN's Q2 Earnings Get a Boost From Dupixent and Eylea HD?

Regeneron's Q2 results could hinge on Dupixent profits and strong Eylea HD, Libtayo sales as investors watch earnings, buybacks and pipeline updates.

AZN Q2 Earnings and Sales Beat, Key Drugs Offset Generic Pressure

AstraZeneca tops Q2 earnings and revenue estimates as strong demand for oncology and rare disease drugs helps offset growing generic competition across key products.

Will GSK's Specialty Medicines Boost Q2 Revenue Growth?

GSK's Specialty Medicines unit is expected to post double-digit CER growth in Q2, driven by newer HIV, RI&I and oncology drugs despite legacy pressures.

Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities

Breakthrough drugs, AI-powered technologies, and soaring global demand are driving one of healthcare’s fastest-growing markets   New York, NY – July 21, 2026 – Market News Updates News Commentary – Diabetes care is going through one of its biggest transformations in decades. Instead of simply helping patients keep their blood sugar under control, today’s therapies […]
The post Next-Generation Diabetes Therapies Are Reshaping Healthcare and Creating MultiBillion-Dollar Revenue Opportunities appeared first on Financial News Media.

Trump's first-term policies helped lower some insulin costs: HHS report

A new study from the Department of Health and Human Services shows that policies in President Donald Trump's first administration helped lower some patients' insulin costs below $35 for a 30-day supply.FOX Business obtained a copy of the new report set to be released as early as Monday. It shows...

Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings

Kalshi is expanding into biotech with contracts on FDA drug approvals from Sanofi and Gilead, as critics warn the wagers invite insider trading.read more...

Sanofi Wins FDA Approval for Wearable Injector Form of Blood Cancer Drug

FDA approves Sanofi's Sarclisa Escena, the first subcutaneous multiple myeloma treatment administered via a hands-free on-body injector.read more...

DNLI Stock Surges 59.4% Year to Date: Is There More Room for Growth?

Denali Therapeutics surges on Avlayah???s FDA approval, PRV sale and pipeline progress, but partnership changes and trial setbacks remain in focus.

R&D Change Underlines Sanofi SA (SNY) Prospects as One of the Best Dividend Stocks to Buy

R&D Change Underlines Sanofi SA (SNY) Prospects as One of the Best Dividend Stocks to Buy...

$SNY Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.14 down -91.36% YoY
• Reported revenue of $12.3B up 14.58% YoY
• In 2026, Sanofi expects sales to grow by around 10% at constant exchange rates, with Sanofi business earnings per share at constant exchange rates expected to grow slightly faster than sales.

Stocktwits

Sanofi-Aventis

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.14 down -91.36% YoY
• Reported revenue of $12.3B up 14.58% YoY
• In 2026, Sanofi expects sales to grow by around 10% at constant exchange rates, with Sanofi business earnings per share at constant exchange rates expected to grow slightly faster than sales.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$41.98
Prev Close	$44.85
Open	$42.02
Dividend Yield	3.64%
50-Day Moving Average	$43.54
Beta	0.32
Avg. Volume	3.95M
PE Ratio	18.71

52-Week High	$52.68
52-Week Low	$40.89
Market Capitalization	$108.06B
EPS (Annual)	$2.41
Price to Book	1.29
Revenue Per Employee	$643,658.13

Feed

News

Sentiment

Earnings

Fundamentals

Info

SNYSanofi-Aventis

Latest SNY News